MAPT and Alzheimer disease: Comparing tau imaging with 18F-AV-1451 PET and beta-amyloid imaging with PiB-PET, it has been suggested that the regional distribution of 18F-AV-1451 retention shows a stronger association with different clinical variants of AD than amyloid distribution [15].